
InspireMD Inc
NASDAQ:NSPR

Intrinsic Value
The intrinsic value of one
NSPR
stock under the Base Case scenario is
4.32
USD.
Compared to the current market price of 2.43 USD,
InspireMD Inc
is
Undervalued by 44%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
InspireMD Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
InspireMD Inc
Balance Sheet Decomposition
InspireMD Inc
Current Assets | 32m |
Receivables | 2.3m |
Other Current Assets | 29.7m |
Non-Current Assets | 7m |
PP&E | 5m |
Other Non-Current Assets | 2m |
Free Cash Flow Analysis
InspireMD Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
InspireMD Inc
Revenue
|
7m
USD
|
Cost of Revenue
|
-5.5m
USD
|
Gross Profit
|
1.5m
USD
|
Operating Expenses
|
-38.6m
USD
|
Operating Income
|
-37.1m
USD
|
Other Expenses
|
1.1m
USD
|
Net Income
|
-36m
USD
|
NSPR Profitability Score
Profitability Due Diligence
InspireMD Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Score
InspireMD Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
NSPR Solvency Score
Solvency Due Diligence
InspireMD Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
InspireMD Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NSPR Price Targets Summary
InspireMD Inc
According to Wall Street analysts, the average 1-year price target for
NSPR
is 4.59 USD
with a low forecast of 4.04 USD and a high forecast of 5.25 USD.
Dividends
Current shareholder yield for NSPR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NSPR
stock under the Base Case scenario is
4.32
USD.
Compared to the current market price of 2.43 USD,
InspireMD Inc
is
Undervalued by 44%.